We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+24.88%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.49B
AUM Growth
+$270M
Cap. Flow
-$9.82M
Cap. Flow %
-0.66%
Top 10 Hldgs %
44.65%
Holding
141
New
11
Increased
24
Reduced
31
Closed
6

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$16.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.48M
3
GSK icon
GSK
GSK
+$5.58M
4
IBM icon
IBM
IBM
+$3.79M
5
PEP icon
PepsiCo
PEP
+$2.62M

Sector Composition

Rank Sector Weight
1 Technology 39.36%
2 Healthcare 16.41%
3 Communication Services 13.59%
4 Consumer Discretionary 13.43%
5 Financials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDT icon
51
Medtronic
MDT
$113B
$6.75M 0.45%
73,611
VRTX icon
52
Vertex Pharmaceuticals
VRTX
$125B
$5.54M 0.37%
+19,080
New +$5.17M
BIIB icon
53
Biogen
BIIB
$29.9B
$5.44M 0.37%
20,323
+15
+0.1% +$4.51K
COF icon
54
Capital One
COF
$127B
$5.11M 0.34%
81,596
BNY
55
Bank of New York Mellon
BNY
$106B
$5.04M 0.34%
130,530
PAYX icon
56
Paychex
PAYX
$42.4B
$4.87M 0.33%
64,230
DGX icon
57
Quest Diagnostics
DGX
$26.4B
$4.64M 0.31%
40,700
AIZ icon
58
Assurant
AIZ
$13.8B
$4.58M 0.31%
44,350
SYF icon
59
Synchrony
SYF
$24.9B
$3.77M 0.25%
170,235
VLO icon
60
Valero Energy
VLO
$90.1B
$3.33M 0.22%
56,550
-20,000
-26% -$1.19M
CRL icon
61
Charles River Laboratories
CRL
$11.4B
$2.98M 0.2%
17,115
-880
-5% -$140K
UNH icon
62
UnitedHealth
UNH
$380B
$2.73M 0.18%
9,250
SEDG icon
63
SolarEdge
SEDG
$2.36B
$2.71M 0.18%
19,490
-790
-4% -$96.6K
PYPL icon
64
PayPal
PYPL
$51.2B
$2.66M 0.18%
15,260
JKHY icon
65
Jack Henry & Associates
JKHY
$11.3B
$2.63M 0.18%
14,315
+1,450
+11% +$253K
SNY icon
66
Sanofi
SNY
$109B
$2.21M 0.15%
43,380
-20,040
-32% -$974K
EG icon
67
Everest Group
EG
$15.8B
$2.19M 0.15%
10,600
CAH icon
68
Cardinal Health
CAH
$54.2B
$2.16M 0.15%
41,395
-13,725
-25% -$708K
NVO
69
Novo Nordisk
NVO
$226B
$2.13M 0.14%
64,920
-37,560
-37% -$1.2M
ELV icon
70
Elevance Health
ELV
$81.3B
$1.88M 0.13%
7,155
+5,415
+311% +$1.44M
ABBV icon
71
AbbVie
ABBV
$468B
$1.84M 0.12%
+18,794
New +$1.65M
MRK icon
72
Merck
MRK
$332B
$1.84M 0.12%
24,880
-1,603
-6% -$121K
COHU icon
73
Cohu
COHU
$1.99B
$1.8M 0.12%
103,636
+12,935
+14% +$199K
UTHR icon
74
United Therapeutics
UTHR
$26.4B
$1.74M 0.12%
14,405
+2,555
+22% +$287K
DIOD icon
75
Diodes
DIOD
$3.61B
$1.61M 0.11%
31,670
+3,065
+11% +$147K

Similar funds

Oak Associates's Q2 2020 Portfolio in Review

As of Q2 2020, Oak Associates held 141 positions worth $1.49B, up 22% from $1.22B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Oak Associates's Q2 2020 filing shows 11 new, 24 increased, 31 reduced and 6 closed positions. Its largest new stake was Digital Realty Trust: 181,127 shares worth $25.7M. The largest sale was Microsoft, an estimated $16.7M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, down from 40% a quarter earlier, followed by Healthcare and Communication Services.

  • Oak Associates's largest Q2 2020 buy was Digital Realty Trust: 181,127 shares worth $25.7M.
  • Oak Associates added most to Meta Platforms (Facebook) in Q2 2020, an estimated $5.14M increase.
  • Oak Associates's biggest Q2 2020 reduction was Microsoft, cutting an estimated $16.7M.
  • Oak Associates fully exited Waters Corp in Q2 2020, selling an estimated $2.5M.
  • Oak Associates's ten largest holdings make up 45% of its $1.49B portfolio in Q2 2020.
  • Oak Associates opened 11 new positions and closed 6 in Q2 2020.
  • Oak Associates's portfolio value rose 22% quarter-over-quarter to $1.49B.

Based on Oak Associates's 13F filing for Q2 2020, filed 11 Aug 2020.